Click to copy
Click to copy

Five Prime Therapeutics: 2Q Earnings Snapshot

August 7, 2019

SOUTH SAN FRANCISCO, Calif. (AP) _ Five Prime Therapeutics Inc. (FPRX) on Wednesday reported a loss of $34.4 million in its second quarter.

The South San Francisco, California-based company said it had a loss of 99 cents per share.

The results missed Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment Research was for a loss of 86 cents per share.

The biotech company that develops treatments targeting cancer and autoimmune diseases posted revenue of $3.3 million in the period, also missing Street forecasts. Five analysts surveyed by Zacks expected $5.5 million.

Five Prime Therapeutics shares have dropped 44% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $5.25, a decrease of 66% in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on FPRX at https://www.zacks.com/ap/FPRX

All contents © copyright 2019 The Associated Press. All rights reserved.